Your browser doesn't support javascript.
loading
Estrogen-containing oral contraceptives are allowable in young women with factor V Leiden heterozygosity without a history of thrombosis.
Budev, Marie M; Abu-Hajir, Majed; Deitcher, Steven R; Gomes, Marcelo P V.
Affiliation
  • Budev MM; Department of Pulmonary and Critical Care Medicine, The Cleveland Clinic Foundation, 9500 Euclid Avenue, A90, Cleveland, OH 44195, USA. budevm@ccf.org
Med Clin North Am ; 87(6): 1225-36, 2003 Nov.
Article in En | MEDLINE | ID: mdl-14680303
ABSTRACT
An 18-year-old woman without significant past medical and surgical history presents to discuss the safety and efficacy of oral contraceptives. She is sexually active and currently relying on condoms alone for birth control. Her cousin had a deep venous thrombosis (DVT) following a pregnancy. As part of the family screening, this patient was identified as a factor V Leiden heterozygote. The risks and benefits of initiating oral contraceptives are discussed.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Factor V / Contraceptives, Oral / Estrogens / Heterozygote Type of study: Prognostic_studies Limits: Adolescent / Female / Humans Language: En Journal: Med Clin North Am Year: 2003 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Factor V / Contraceptives, Oral / Estrogens / Heterozygote Type of study: Prognostic_studies Limits: Adolescent / Female / Humans Language: En Journal: Med Clin North Am Year: 2003 Document type: Article